BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1973852)

  • 1. Long-term assays for carcinogenicity.
    Della Porta G; Dragani TA
    Teratog Carcinog Mutagen; 1990; 10(2):137-45. PubMed ID: 1973852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medium-term bioassays as alternative carcinogenicity test.
    Ito N; Imaida K; Tamano S; Hagiwara A; Shirai T
    J Toxicol Sci; 1998 Jul; 23 Suppl 2():103-6. PubMed ID: 9760442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2-year rodent bioassay in drug and chemical carcinogenesis testing: Sensitivity, according to the framework of carcinogenic action.
    Suarez-Torres JD; Jimenez-Orozco FA; Ciangherotti CE
    Toxicol Mech Methods; 2020 Jul; 30(6):462-475. PubMed ID: 32338171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal mouse model: review of methods and results.
    McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
    Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2-year rodent bioassay in drug and chemical carcinogenicity testing: Performance, utility, and configuration for cancer hazard identification.
    Suarez-Torres JD; Orozco CA; Ciangherotti CE
    J Pharmacol Toxicol Methods; 2021; 110():107070. PubMed ID: 33905862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
    Osimitz TG; Droege W; Boobis AR; Lake BG
    Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medium-term bioassays for carcinogenicity of chemical mixtures.
    Ito N; Imaida K; Hirose M; Shirai T
    Environ Health Perspect; 1998 Dec; 106 Suppl 6(Suppl 6):1331-6. PubMed ID: 9860889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
    Ashby J; Paton D
    Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the carcinogenicity of chemicals in humans from rodent bioassay data.
    Goodman G; Wilson R
    Environ Health Perspect; 1991 Aug; 94():195-218. PubMed ID: 1954931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium-term liver and multi-organ carcinogenesis bioassays for carcinogens and chemopreventive agents.
    Ito N; Hasegawa R; Imaida K; Hirose M; Shirai T
    Exp Toxicol Pathol; 1996 Feb; 48(2-3):113-9. PubMed ID: 8672864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Tg rasH2 mouse in cancer hazard identification.
    Morton D; Alden CL; Roth AJ; Usui T
    Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the carcinogenicity prediction and battery selection method to recent National Toxicology Program short-term test data.
    Ennever FK; Rosenkranz HS
    Environ Mol Mutagen; 1989; 13(4):332-8. PubMed ID: 2737184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enhanced thirteen-week bioassay as an alternative for screening for carcinogenesis factors.
    Cohen SM
    Asian Pac J Cancer Prev; 2010; 11(1):15-7. PubMed ID: 20593920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation-promotion model for assessment of carcinogenicity: medium-term liver bioassay in rats for rapid detection of carcinogenic agents.
    Imaida K; Fukushima S
    J Toxicol Sci; 1996 Dec; 21(5):483-7. PubMed ID: 9035059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternatives to the 2-species bioassay for the identification of potential human carcinogens.
    Ashby J
    Hum Exp Toxicol; 1996 Mar; 15(3):183-202. PubMed ID: 8839204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An examination of the association between maximum-tolerated dose and carcinogenicity in 326 long-term studies in rats and mice.
    Haseman JK; Seilkop SK
    Fundam Appl Toxicol; 1992 Aug; 19(2):207-13. PubMed ID: 1516777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.